← TrialMatch
HomeTrials

Ventripoint Single Ventricle Study

This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.

Condition(s)Congenital Heart Disease, Single-ventricle
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThis study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.
Who can participateInclusion Criteria: * All patients with functional single ventricles will be included, regardless of age or surgical palliation stage, who have had or are having a clinically ordered transthoracic echocardiogram and/or cardiac MRI. Exclusion Criteria: * Patients with congenital heart disease other than functional single ventricles, patients with single ventricle physiology (but not single ventricle anatomy) following a biventricular conversion pathway, or patients unable to understand or consent in English will be excluded.
SexAll
Lead sponsorDuke University
LocationsDurham, North Carolina, United States
Start date2022-07-08
NCT IDNCT05262907
Official listinghttps://clinicaltrials.gov/study/NCT05262907

🔍 Search all trials →